Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

Moderna: Funding the messenger

Moderna developing mRNA technology for faster, cheaper therapeutic proteins

January 28, 2013 8:00 AM UTC

Moderna Therapeutics Inc. expects its messenger RNA Therapeutics platform can reduce the time and expense of producing therapeutic proteins compared with recombinant technologies.

The company delivers modified mRNAs by subcutaneous or intramuscular injection, and the molecules are translated into therapeutic proteinsin vivo...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article